SYMBICORT: payments to doctors
Payments that named SYMBICORT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3M
- Providers
- 31,900
- Transactions
- 131,401
- Average per transaction
- $23
The per-transaction average — $23 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 31,900 providers the average total is $95, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $2,993,174 | 99.3% |
| Astrazeneca AB | $21,649 | 0.7% |
| Astrazeneca UK Limited | $500 | 0.0% |